Cargando…
Exploring potential anticoagulant drug formulations using thrombin generation test
Many anticoagulant drugs inhibiting proteins of the coagulation cascade have been developed. The main targets of anticoagulant drugs are thrombin and factor Xa; inhibiting these factors delays thrombus growth, thus preventing thrombosis while increasing bleeding risk. A balance between thrombosis an...
Autores principales: | Zavyalova, Elena, Kopylov, Alexey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600416/ https://www.ncbi.nlm.nih.gov/pubmed/28955812 http://dx.doi.org/10.1016/j.bbrep.2015.11.011 |
Ejemplares similares
-
Evaluation of Antithrombotic Activity of Thrombin DNA Aptamers by a Murine Thrombosis Model
por: Zavyalova, Elena, et al.
Publicado: (2014) -
The Evaluation of Pharmacodynamics and Pharmacokinetics of Anti-thrombin DNA Aptamer RA-36
por: Zavyalova, Elena, et al.
Publicado: (2017) -
Anticoagulants and the Propagation Phase of Thrombin Generation
por: Orfeo, Thomas, et al.
Publicado: (2011) -
Putative Mechanisms Underlying High Inhibitory Activities of Bimodular DNA Aptamers to Thrombin
por: Zavyalova, Elena G., et al.
Publicado: (2019) -
Energy Transfer as A Driving Force in Nucleic Acid–Protein Interactions
por: Zavyalova, Elena, et al.
Publicado: (2019)